News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.50d agobearish
Did VOXZOGO’s Hypochondroplasia Win and New R&D Hire Just Reframe BioMarin’s (BMRN) Investment Narrative?24/7 Wall St.51d agoneutral
Pfizer’s Dividend Yield Is Enormous. But Is the Payout Still Growing?Motley Fool51d agobullish
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?Simply Wall St.51d agoneutral
Bristol Myers Squibb (BMY) Funds India Lung Cancer Screening Research Beyond SmokingBioPharma Dive51d agoneutral
Ultragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drugSimply Wall St.54d agoneutral
The Bull Case For Bristol Myers Squibb (BMY) Could Change Following Arlo-cel’s Positive Phase 2 Myeloma DataMotley Fool56d agobullish
Should You Buy Bristol Myers Squibb Stock Right Now for the Yield Alone?24/7 Wall St.57d agoneutral
How Much Do You Really Need Invested in Bristol Myers Squibb to Collect $10,000 a Year?